Q3 2025 net product revenue for ZORYVE® (roflumilast) was $99.2 million, a 122% increase compared to Q3 of 2024, and a 22% increase compared to ...

Shares in Arcutis Biotherapeutics (NASDAQ: ARQT) soared by almost 30% in trading to 10:30 a.m. ET today. The move comes after ...

Skin conditions with Parkinson’s disease are common and manageable. By paying attention to these symptoms, patients can ...

Arcutis Biotherapeutics surged as Q3 earnings beat forecasts and Zoryve sales boomed. Click for my updated look at ARQT stock ...

INDICATIONS ZORYVE cream, 0.05%, is indicated for topical treatment of mild to moderate atopic dermatitis in pediatric patients 2 to 5 years of age. ZORYVE cream, 0.15%, is indicated for topical ...

New clinical data demonstrate Zoryve's effectiveness in treating atopic dermatitis, reducing sleep disruptions and maintaining disease control with minimal adverse events across all ages.

This article was reviewed by Knox Beasley, MD. Exosomes for Hair Loss: Costs, Safety, Efficacy, & Benefits The deeper you ...

Arcutis Biotherapeutics has recently seen its consensus analyst price target hold steady at $23.38, even as expectations around its risk profile and growth have shifted slightly. This stability comes ...

It’s Eczema Awareness Month, and dermatologist Dr Bernard Ho explains why this often misunderstood condition is more than ...

Arcutis achieved earlier-than-expected profitability and continues expanding Zoryve's label for broader indications. Read why ...

For symptoms of scalp psoriasis, home treatments like olive oil, oatmeal, and apple cider vinegar may provide relief and make ...

Tea tree oil may support hair growth and control oil production, but using it improperly may increase the risk of hair damage ...